Open Forum

Leprosy review

Lehlohonolo Makhakhe
South African Family Practice | Vol 63, No 1 : Part 4| a5311 | DOI: https://doi.org/10.4102/safp.v63i1.5311 | © 2021 Lehlohonolo Makhakhe | This work is licensed under CC Attribution 4.0
Submitted: 02 April 2021 | Published: 29 October 2021

About the author(s)

Lehlohonolo Makhakhe, Department of Dermatology, Faculty of Health Science, University of the Free State, Bloemfontein, South Africa; and, The South African Institute of Dermatology, Bloemfontein, South Africa

Abstract

Leprosy (Hansen’s disease) can affect multiple organs and body structures. Skin signs are typically observed in the early phase of the disease, hence being the first identifiable signs to propel clinical suspicion. Leprosy predominantly affects the skin and peripheral nerves. The disease has been documented many centuries preceding the biblical era. Over many decades, the classification of Hansen’s disease has changed as modern medical science evolved. Patients with leprosy are usually subjected to discrimination, rejection from society and can suffer from social stigma, poor quality of life (QoL), low self-esteem and permanent disfigurements. Studies have shown that leprosy has a significant negative impact on the patients’ QoL. Leprosy is often not suspected by practicing clinicians because it is no longer emphasised in the medical curricula. In modern years, attention has gradually shifted from leprosy to tuberculosis (TB) and human immunodeficiency virus (HIV).

Keywords

leprosy; Hansen’s disease; quality of life; self-esteem; HIV; TB

Metrics

Total abstract views: 2984
Total article views: 3089


Crossref Citations

No related citations found.